• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射用免疫球蛋白制品对日本分离的肠道病毒 D68 株的中和活性。

Neutralizing activity of intravenous immune globulin products against enterovirus D68 strains isolated in Japan.

机构信息

Department of Virology 2, National Institute of Infectious Diseases, Tokyo, Japan.

Department of Infectious Disease Research, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.

出版信息

BMC Infect Dis. 2023 Jul 18;23(1):481. doi: 10.1186/s12879-023-08429-z.

DOI:10.1186/s12879-023-08429-z
PMID:37464326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10394975/
Abstract

BACKGROUND

Enterovirus D68 (EV-D68), belonging to Enterovirus D, is a unique human enterovirus mainly associated with common respiratory diseases. However, EV-D68 can cause severe respiratory diseases, and EV-D68 endemic is epidemiologically linked to current global epidemic of acute flaccid myelitis.

METHODS

In this study, we measured neutralizing antibody titers against six clinical EV-D68 isolates in nine intravenous immune globulin (IVIG) products commercially available in Japan to assess their potential as therapeutic options for severe EV-D68 infection.

RESULTS

Seven IVIG products manufactured from Japanese donors contained high neutralizing antibody titers (IC = 0.22-85.01 µg/mL) against all six EV-D68 strains. Apparent differences in neutralizing titers among the six EV-D68 strains were observed for all IVIG products derived from Japanese and non-Japanese blood donors.

CONCLUSIONS

High levels of EV-D68-neutralizing antibodies in IVIG products manufactured from Japanese donors suggest that anti-EV-D68 antibodies are maintained in the Japanese donor population similarly as found in foreign blood donors. Apparent differences in neutralizing antibody titers against the six EV-D68 strains suggest distinct antigenicity among the strains used in this study regardless of the genetic similarity of EV-D68.

摘要

背景

肠道病毒 D68(EV-D68)属于肠道病毒 D 组,是一种独特的人类肠道病毒,主要与常见的呼吸道疾病有关。然而,EV-D68 可引起严重的呼吸道疾病,并且 EV-D68 的流行与当前全球急性弛缓性脊髓炎的流行在流行病学上有关。

方法

在这项研究中,我们测量了 9 种日本市售静脉注射免疫球蛋白(IVIG)产品对 6 种临床 EV-D68 分离株的中和抗体滴度,以评估其作为严重 EV-D68 感染治疗选择的潜力。

结果

7 种来自日本供体的 IVIG 产品对所有 6 种 EV-D68 株均含有高中和抗体滴度(IC = 0.22-85.01 µg/mL)。来自日本和非日本供体的所有 IVIG 产品对 6 种 EV-D68 株的中和滴度均存在明显差异。

结论

来自日本供体的 IVIG 产品中含有高水平的 EV-D68 中和抗体,表明抗 EV-D68 抗体在日本供体人群中得到维持,与国外供体相似。对 6 种 EV-D68 株的中和抗体滴度存在明显差异,表明本研究中使用的株之间存在明显的抗原性,而 EV-D68 的遗传相似性则不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b7/10394975/dca27fab545d/12879_2023_8429_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b7/10394975/dca27fab545d/12879_2023_8429_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b7/10394975/dca27fab545d/12879_2023_8429_Fig1_HTML.jpg

相似文献

1
Neutralizing activity of intravenous immune globulin products against enterovirus D68 strains isolated in Japan.静脉注射用免疫球蛋白制品对日本分离的肠道病毒 D68 株的中和活性。
BMC Infect Dis. 2023 Jul 18;23(1):481. doi: 10.1186/s12879-023-08429-z.
2
Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products.商用静脉注射免疫球蛋白产品对2014年美国疫情中分离出的肠道病毒D68的中和作用。
J Clin Virol. 2015 Aug;69:172-5. doi: 10.1016/j.jcv.2015.06.086. Epub 2015 Jun 19.
3
Concurrent Community Transmission of Enterovirus D68 With Human Rhinoviruses and Respiratory Syncytial Virus Among Children in Sendai, Japan.日本仙台地区儿童中肠道病毒 D68 与人鼻病毒和呼吸道合胞病毒的同时社区传播。
Pediatr Infect Dis J. 2018 May;37(5):394-400. doi: 10.1097/INF.0000000000001768.
4
Neutralizing Antibody Given after Paralysis Onset Reduces the Severity of Paralysis Compared to Nonspecific Antibody-Treated Controls in a Mouse Model of EV-D68-Associated Acute Flaccid Myelitis.在 EV-D68 相关急性弛缓性脊髓炎的小鼠模型中,与非特异性抗体治疗对照组相比,瘫痪发病后给予中和抗体可降低瘫痪严重程度。
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0022722. doi: 10.1128/aac.00227-22. Epub 2022 Jul 27.
5
Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016.肠道病毒 D68 血清学调查:2006 年至 2016 年荷兰流行情况的证据。
Euro Surveill. 2019 Aug;24(35). doi: 10.2807/1560-7917.ES.2019.24.35.1800671.
6
Enterovirus D-68 Molecular Virology, Epidemiology, and Treatment: an Update and Way Forward.肠道病毒 D-68 的分子病毒学、流行病学和治疗:最新进展及未来方向。
Infect Disord Drug Targets. 2021;21(3):320-327. doi: 10.2174/1871526520666200715101230.
7
Detection of intrathecal antibodies to diagnose enterovirus infections of the central nervous system.检测脑脊水中针对肠道病毒感染中枢神经系统的抗体。
J Clin Virol. 2022 Jul;152:105190. doi: 10.1016/j.jcv.2022.105190. Epub 2022 May 23.
8
Seroepidemiology of enterovirus D68 in a healthy population in Beijing, China, between 2012 and 2017: A retrospective study.2012 年至 2017 年期间中国北京健康人群中肠道病毒 D68 的血清流行病学:一项回顾性研究。
J Med Virol. 2021 Jun;93(6):3524-3531. doi: 10.1002/jmv.26132. Epub 2020 Oct 5.
9
Distinct genetic clades of enterovirus D68 detected in 2010, 2013, and 2015 in Osaka City, Japan.2010年、2013年和2015年在日本大阪市检测到的肠道病毒D68的不同基因分支。
PLoS One. 2017 Sep 13;12(9):e0184335. doi: 10.1371/journal.pone.0184335. eCollection 2017.
10
A cross-sectional seroepidemiology study of EV-D68 in China.中国肠道病毒 D68 的横断面血清流行病学研究。
Emerg Microbes Infect. 2018 Jun 6;7(1):99. doi: 10.1038/s41426-018-0103-4.

本文引用的文献

1
Neutralizing Antibody Given after Paralysis Onset Reduces the Severity of Paralysis Compared to Nonspecific Antibody-Treated Controls in a Mouse Model of EV-D68-Associated Acute Flaccid Myelitis.在 EV-D68 相关急性弛缓性脊髓炎的小鼠模型中,与非特异性抗体治疗对照组相比,瘫痪发病后给予中和抗体可降低瘫痪严重程度。
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0022722. doi: 10.1128/aac.00227-22. Epub 2022 Jul 27.
2
Seroepidemiology of enterovirus D68 infection in Kuala Lumpur, Malaysia between 2013 and 2015.2013 年至 2015 年期间马来西亚吉隆坡肠道病毒 D68 感染的血清流行病学研究。
J Med Virol. 2022 Jun;94(6):2607-2612. doi: 10.1002/jmv.27381. Epub 2021 Oct 13.
3
Emerging Non-Polio Enteroviruses recognized in the framework of the Acute Flaccid Paralyses (AFP) surveillance system in Northern Italy, 2016-2018.
2016-2018 年,在意大利北部急性弛缓性麻痹(AFP)监测系统框架内发现的新型非脊髓灰质炎肠道病毒。
Int J Infect Dis. 2021 May;106:36-40. doi: 10.1016/j.ijid.2021.03.057. Epub 2021 Mar 23.
4
Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis.美国肠道病毒 D68 的流行病学动态及其对急性弛缓性脊髓炎的影响。
Sci Transl Med. 2021 Mar 10;13(584). doi: 10.1126/scitranslmed.abd2400.
5
Outbreak of Enterovirus D68 Among Children in Japan-Worldwide Circulation of Enterovirus D68 Clade B3 in 2018.日本儿童中肠病毒 D68 的爆发——2018 年肠病毒 D68 分支 B3 的全球传播。
Pediatr Infect Dis J. 2021 Jan;40(1):6-10. doi: 10.1097/INF.0000000000002889.
6
Enterovirus D68-Associated Acute Flaccid Myelitis, United States, 2020.2020 年美国肠病毒 D68 相关急性弛缓性脊髓炎。
Emerg Infect Dis. 2020 Oct;26(10). doi: 10.3201/eid2610.201630. Epub 2020 Aug 24.
7
Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease.人源抗体中和肠道病毒 D68 并预防感染和麻痹性疾病。
Sci Immunol. 2020 Jul 3;5(49). doi: 10.1126/sciimmunol.aba4902.
8
Acute Flaccid Myelitis in Children in Zhejiang Province, China.中国浙江省儿童急性弛缓性脊髓炎
Front Neurol. 2020 May 22;11:360. doi: 10.3389/fneur.2020.00360. eCollection 2020.
9
Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017.2017 年台湾肠病毒 D68 血清流行病学的横断面研究。
PLoS One. 2020 Mar 10;15(3):e0230180. doi: 10.1371/journal.pone.0230180. eCollection 2020.
10
Pan-viral serology implicates enteroviruses in acute flaccid myelitis.泛病毒血清学提示肠道病毒与急性弛缓性脊髓炎有关。
Nat Med. 2019 Nov;25(11):1748-1752. doi: 10.1038/s41591-019-0613-1. Epub 2019 Oct 21.